NIAID Banner Logo Image

Opportunistic Infections Citation List: August 16 - August 29, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Spiro Fused Diterpene-indole Alkaloids from a Creek-bottom-derived Aspergillus terreus. Cai, S., L. Du, A.L. Gerea, J.B. King, J. You, and R.H. Cichewicz. Organic Letters, 2013. 15(16): p. 4186-4189. PMID[23924243].

[PubMed]. OI_0816-082913.


2. Amphotericin B-copper(II) Complex as a Potential Agent with Higher Antifungal Activity against Candida albicans. Chudzik, B., I.B. Tracz, G. Czernel, M.J. Fiolka, G. Borsuk, and M. Gagos. European Journal of Pharmaceutical Sciences, 2013. 49(5): p. 850-857. PMID[23791641].

[PubMed]. OI_0816-082913.


3. Cytotoxicity of Brazilian Plant Extracts against Oral Microorganisms of Interest to Dentistry. De Oliveira, J.R., V.C. de Castro, P. das Gracas Figueiredo Vilela, S.E. Camargo, C.A. Carvalho, A.O. Jorge, and L.D. de Oliveira. BMC Complementary and Alternative Medicine, 2013. 13: p. 208. PMID[23945270].

[PubMed]. OI_0816-082913.


4. Evaluation of (4-Aminobutyloxy)quinolines as a Novel Class of Antifungal Agents. Vandekerckhove, S., H.G. Tran, T. Desmet, and M. D'Hooghe. Bioorganic & Medicinal Chemistry Letters, 2013. 23(16): p. 4641-4643. PMID[23838261].

[PubMed]. OI_0816-082913.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

5. Comparing Adjuvanted H28 and Modified Vaccinia Virus Ankara Expressing H28 in a Mouse and a Non-human Primate Tuberculosis Model. Billeskov, R., J.P. Christensen, C. Aagaard, P. Andersen, and J. Dietrich. Plos One, 2013. 8(8): p. e72185. PMID[23977248].

[PubMed]. OI_0816-082913.


6. Naphthoquinones Isolated from Diospyros anisandra Exhibit Potent Activity against Pan-resistant First-line Drugs Mycobacterium tuberculosis Strains. Uc-Cachon, A.H., R. Borges-Argaez, S. Said-Fernandez, J. Vargas-Villarreal, F. Gonzalez-Salazar, M. Mendez-Gonzalez, M. Caceres-Farfan, and G.M. Molina-Salinas. Pulmonary Pharmacology & Therapeutics, 2013. [Epub ahead of print]. PMID[23968826].

[PubMed]. OI_0816-082913.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

7. Antimalarial and Cytotoxic Activities of Chiral Triamines. Dellai, A., J. Appel, A. Bouraoui, S. Croft, and A. Nefzi. Bioorganic & Medicinal Chemistry Letters, 2013. 23(16): p. 4579-4582. PMID[23835293].

[PubMed]. OI_0816-082913.


8. Small Molecule Plasmodium FKBP35 Inhibitor as a Potential Antimalaria Agent. Harikishore, A., M. Niang, S. Rajan, P.R. Preiser, and H.S. Yoon. Scientific Reports, 2013. 3: p. 2501. PMID[23974147].

[PubMed]. OI_0816-082913.


9. Transdermal Glyceryl Trinitrate as an Effective Adjunctive Treatment with Artemether for Late Stage Experimental Cerebral Malaria. Orjuela-Sanchez, P., P.K. Ong, G.M. Zanini, B. Melchior, Y.C. Martins, D. Meays, J.A. Frangos, and L.J. Carvalho. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23979751].

[PubMed]. OI_0816-082913.


10. Fusidic acid Is an Effective Treatment against Toxoplasma gondii and Listeria Monocytogenes in Vitro, but Not in Mice. Payne, A.J., L.M. Neal, and L.J. Knoll. Parasitology Research, 2013. [Epub ahead of print]. PMID[23949312].

[PubMed]. OI_0816-082913.


11. In Vivo Antimalarial Activity of Novel 2-Hydroxy-3-anilino-1,4-naphthoquinones Obtained by Epoxide Ring-opening Reaction. Rezende, L.C., F. Fumagalli, M.S. Bortolin, M.G. Oliveira, M.H. Paula, V.F. Andrade-Neto, and S. Emery Fda. Bioorganic & Medicinal Chemistry Letters, 2013. 23(16): p. 4583-4586. PMID[23850202].

[PubMed]. OI_0816-082913.

ANTIPROTOZOAL COMPOUNDS

12. In Vitro Effects of Novel Ruthenium Complexes in Neospora caninum and Toxoplasma gondii Tachyzoites. Barna, F., K. Debache, C.A. Vock, T. Kuster, and A. Hemphill. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23979747].

[PubMed]. OI_0816-082913.


13. Effect of Nitaxozanide and Pyrimethamine on Astrocytes Infected by Toxoplasma gondii in Vitro. Galvan-Ramirez, M.D., J. Duenas-Jimenez, L. Rodriguez-Perez, R. Troyo-Sanroman, M. Ramirez-Herrera, and T. Garcia-Iglesias. Archives of Medical Research, 2013. [Epub ahead of print]. PMID[23973195].

[PubMed]. OI_0816-082913.


14. Fusidic Acid Is an Effective Treatment against Toxoplasma gondii and Listeria monocytogenes in Vitro, but Not in Mice. Payne, A.J., L.M. Neal, and L.J. Knoll. Parasitology Research, 2013. [Epub ahead of print]. PMID[23949312].

[PubMed]. OI_0816-082913.

Citations from the ISI Web of Knowledge Listings for O.I.

15. Synthesis of Some New 3,5-Diamino-4-(4 '-fluorophenylazo)-1-aryl/heteroarylpyrazoles as Antimicrobial Agents. Aggarwal, R., V. Kumar, G.K. Gupta, and V. Kumar. Medicinal Chemistry Research, 2013. 22(8): p. 3566-3573. ISI[000320673200003].

[WOS]. OI_0816-082913.


16. Differences in Composition of Honey Samples and Their Impact on the Antimicrobial Activities against Drug Multiresistant Bacteria and Pathogenic Fungi. Al-Waili, N., A. Al Ghamdi, M.J. Ansari, Y. Al-Attal, A. Al-Mubarak, and K. Salom. Archives of Medical Research, 2013. 44(4): p. 307-316. ISI[000321994100009].

[WOS]. OI_0816-082913.


17. Synthesis, Characterization, and in Vitro anti-Mycobacterium tuberculosis Activity of Terpene Schiff Bases. Bhat, M.A. and M.A. Al-Omar. Medicinal Chemistry Research, 2013. 22(9): p. 4522-4528. ISI[000322181300048].

[WOS]. OI_0816-082913.


18. Antimicrobial Activity of Schiff Bases of Coumarin-Incorporated 1,3,4-Oxadiazole Derivatives: An in Vitro Evaluation. Bhat, M.A., M.A. Al-Omar, and N. Siddiqui. Medicinal Chemistry Research, 2013. 22(9): p. 4455-4458. ISI[000322181300042].

[WOS]. OI_0816-082913.


19. Isolation of (-)-Olivil-9 '-O-beta-D-glucopyranoside from Sambucus williamsii and Its Antifungal 5ffects with Membrane-disruptive Action. Choi, H., J. Lee, Y.S. Chang, E.R. Woo, and D.G. Lee. Biochimica Et Biophysica Acta-Biomembranes, 2013. 1828(8): p. 2002-2006. ISI[000320838500038].

[WOS]. OI_0816-082913.


20. Synthesis of New Quinoline-2-pyrazoline-based Thiazolinone Derivatives as Potential Antimicrobial Agents. Desai, N.C., V.V. Joshi, and K.M. Rajpara. Medicinal Chemistry Research, 2013. 22(8): p. 3663-3674. ISI[000320673200012].

[WOS]. OI_0816-082913.


21. Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method. Espinel-Ingroff, A., A. Chowdhary, G.M. Gonzalez, C. Lass-Florl, E. Martin-Mazuelos, J. Meis, T. Pelaez, M.A. Pfaller, and J. Turnidge. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3823-3828. ISI[000321761800046].

[WOS]. OI_0816-082913.


22. Antimicrobial Polymer Films Functionalized with Cyclodextrins. Grigoriu, A.M., C. Luca, E. Horoba, and S. Dunca. Revista de Chimie, 2013. 64(6): p. 606-611. ISI[000321025000010].

[WOS]. OI_0816-082913.


23. Synthesis, Antitubercular Activity, and QSAR Analysis of Substituted Nitroaryl Analogs: Chalcone, Pyrazole, Isoxazole, and Pyrimidines. Gupta, R.A. and S.G. Kaskhedikar. Medicinal Chemistry Research, 2013. 22(8): p. 3863-3880. ISI[000320673200032].

[WOS]. OI_0816-082913.


24. Identification and Mechanism of Action of the Plant Defensin NaD1 as a New Member of the Antifungal Drug Arsenal against Candida albicans. Hayes, B.M.E., M.R. Bleackley, J.L. Wiltshire, M.A. Anderson, A. Traven, and N.L. van der Weerden. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3667-3675. ISI[000321761800026].

[WOS]. OI_0816-082913.


25. Cell Wall Perturbation Sensitizes Fungi to the Antimalarial Drug Chloroquine. Islahudin, F., C. Khozoie, S. Bates, K.N. Ting, R.J. Pleass, and S.V. Avery. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3889-3896. ISI[000321761800054].

[WOS]. OI_0816-082913.


26. Synthesis, Characterization, and SAR Studies of New (1H-Indol-3-yl)alkyl-3-(1H-indol-3-yl)propanamide Derivatives as Possible Antimicrobial and Antitubercular Agents. Karuvalam, R.P., R. Pakkath, K.R. Haridas, R. Rishikesan, and N.S. Kumari. Medicinal Chemistry Research, 2013. 22(9): p. 4437-4454. ISI[000322181300041].

[WOS]. OI_0816-082913.


27. Development of Flavonoid-based Inverse Agonists of the Key Signaling Receptor US28 of Human Cytomegalovirus. Kralj, A., M.T. Nguyen, N. Tschammer, N. Ocampo, Q. Gesiotto, M.R. Heinrich, and O. Phanstiel. Journal of Medicinal Chemistry, 2013. 56(12): p. 5019-5032. ISI[000321237100016].

[WOS]. OI_0816-082913.


28. Synthesis and Pharmacological Evaluation of Some Novel 4-Isopropyl thiazole-based sulfonyl Derivatives as Potent Antimicrobial and Antitubercular Agents. Kumar, G.V.S., Y.R. Prasad, and S.M. Chandrashekar. Medicinal Chemistry Research, 2013. 22(9): p. 4239-4252. ISI[000322181300020].

[WOS]. OI_0816-082913.


29. Synthesis and Antimicrobial Activity of Novel bis-Azaphenothiazines. Kushwaha, K., R. Sakhuja, and S.C. Jain. Medicinal Chemistry Research, 2013. 22(9): p. 4459-4467. ISI[000322181300043].

[WOS]. OI_0816-082913.


30. Potentiation of Azole Antifungals by 2-Adamantanamine. LaFleur, M.D., L.M. Sun, I. Lister, J. Keating, A. Nantel, L.S. Long, M. Ghannoum, J. North, R.E. Lee, K. Coleman, T. Dahl, and K. Lewis. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3585-3592. ISI[000321761800016].

[WOS]. OI_0816-082913.


31. Free Radicals Scavenging Activity, Cytotoxicity and Anti-parasitic Activity of Essential Oil of Psidium guajava L. Leaves against Toxoplasma gondii. Lee, W.C., R. Mahmud, R. Noordin, S.P. Piaru, S. Perumal, and S. Ismail. Journal of Essential Oil Bearing Plants, 2013. 16(1): p. 32-38. ISI[000321522900005].

[WOS]. OI_0816-082913.


32. Enhanced Efficacy of Synergistic Combinations of Antimicrobial Peptides with Caspofungin Versus Candida albicans in Insect and Murine Models of Systemic Infection. MacCallum, D.M., A.P. Desbois, and P.J. Coote. European Journal of Clinical Microbiology & Infectious Diseases, 2013. 32(8): p. 1055-1062. ISI[000321637700014].

[WOS]. OI_0816-082913.


33. Validation of Antimycobacterial Plants Used by Traditional Healers in Three Districts of the Limpopo Province (South Africa). Masoko, P. and K.M. Nxumalo. Evidence-Based Complementary and Alternative Medicine, 2013. [Epub ahead of print]. ISI[000322466500001].

[WOS]. OI_0816-082913.


34. Identification of Volatile Oil Components of Nepeta binaludensis Jamzad by GC-MS and C-13-NMR Methods and Evaluation of Its Antimicrobial Activity. Mohammadpour, N., S.A. Emami, and J. Asili. Journal of Essential Oil Bearing Plants, 2013. 16(1): p. 102-107. ISI[000321522900014].

[WOS]. OI_0816-082913.


35. Cationic Antimicrobial Peptides and Biogenic Silver Nanoparticles Kill Mycobacteria without Eliciting DNA Damage and Cytotoxicity in Mouse Macrophages. Mohanty, S., P. Jena, R. Mehta, R. Pati, B. Banerjee, S. Patil, and A. Sonawane. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3688-3698. ISI[000321761800029].

[WOS]. OI_0816-082913.


36. Synthesis and Biological Evaluation of Cationic Fullerene quinazolinone Conjugates and Their Binding Mode with Modeled Mycobacterium tuberculosis Hypoxanthine-Guanine Phosphoribosyltransferase Enzyme. Patel, M.B., S.P. Kumar, N.N. Valand, Y.T. Jasrai, and S.K. Menon. Journal of Molecular Modeling, 2013. 19(8): p. 3201-3217. ISI[000321922600028].

[WOS]. OI_0816-082913.


37. Two Human Host Defense Ribonucleases against Mycobacteria, the Eosinophil Cationic Protein (RNase 3) and RNase 7. Pulido, D., M. Torrent, D. Andreu, M.V. Nogues, and E. Boix. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3797-3805. ISI[000321761800043].

[WOS]. OI_0816-082913.


38. Microwave-assisted Synthesis of Novel 4h-Chromene Derivatives Bearing 2-Aryloxyquinoline and Their Antimicrobial Activity Assessment. Sangani, C.B., N.M. Shah, M.P. Patel, and R.G. Patel. Medicinal Chemistry Research, 2013. 22(8): p. 3831-3842. ISI[000320673200029].

[WOS]. OI_0816-082913.


39. High-throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for Identification of Candida albicans Biofilm Inhibitors. Siles, S.A., A. Srinivasan, C.G. Pierce, J.L. Lopez-Ribot, and A.K. Ramasubramanian. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3681-3687. ISI[000321761800028].

[WOS]. OI_0816-082913.


40. Anti-aspergillus Activity of Green Coffee 5-O-Caffeoyl quinic acid and Its Alkyl Esters. Suarez-Quiroz, M.L., A.A. Campos, G.V. Alfaro, O. Gonzalez-Rios, P. Villeneuve, and M.C. Figueroa-Espinoza. Microbial Pathogenesis, 2013. 61-62: p. 51-56. ISI[000321883100009].

[WOS]. OI_0816-082913.


41. Synthesis and Antimicrobial Activity of Amines with Azaxanthene Fragments. Yunnikova, L.P., V.Y. Gorokhov, T.V. Makhova, and G.A. Aleksandrova. Pharmaceutical Chemistry Journal, 2013. 47(3): p. 139-141. ISI[000322178900004].

[WOS]. OI_0816-082913.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022